Evidence map›Paper›PMID 33380244›Full record

ArticleBioengineered2021

Fenretinide regulates macrophage polarization to protect against experimental colitis induced by dextran sulfate sodium.

Yong Cao, Yan Lin, Yan Sun, Weiyu Liu, Yichuan Shao, Changqing Zheng

Open access · goldAbstract read
In one paragraph

Article in Bioengineered, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Identifying MS4A6AHeliyon · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Yong CaoDepartment of Gastroenterology, Shengjing Hospital of China Medical University , Shenyang, People's Republic of China.
Yan LinDepartment of Gastroenterology, Shengjing Hospital of China Medical University , Shenyang, People's Republic of China.
Yan SunDepartment of Gastroenterology, Shengjing Hospital of China Medical University , Shenyang, People's Republic of China.
Weiyu LiuDepartment of Gastroenterology, The People's Hospital of Liaoning Province , Shenyang, People's Republic of China.
Yichuan ShaoSchool of Information Engineering, Shenyang University , Shenyang, People's Republic of China.
Changqing ZhengDepartment of Gastroenterology, Shengjing Hospital of China Medical University , Shenyang, People's Republic of China.
China Medical University · CNLiaoning Provincial People's Hospital · CNShenyang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fenretinide (4-HPR), a synthetic retinoid, has attracted attention for its anti-inflammation activity. However, few studies have evaluated the effects of 4-HPR on ulcerative colitis (UC). The present study was performed to investigate the therapeutic effects of 4-HPR on UC, and to explore the mechanisms mainly focused on macrophage polarization involved in this progress. Intraperitoneally administered 4-HPR particularly at dose of 100 mg/kg obviously alleviated UC symptoms and restrained the mRNA expression of colonic IL-1β, IL-6, and TNF-α in dextran sulfate sodium (DSS)-induced mice. Further analysis showed that 4-HPR decreased the mRNA expression of M1 macrophage markers IL-12 and iNOS, while increased M2 macrophage markers Ym1, Arg1 and MRC1 in colonic tissue of mice received DSS. Consistently, an

Indexed as

AnimalsCell PolarityColitis, UlcerativeColonDextran SulfateDisease Models, AnimalFenretinideMacrophagesMaleMiceMice, Inbred C57BLProtective AgentsRAW 264.7 CellsDextran SulfateFenretinideProtective AgentsFenretinidemacrophage polarizationPPAR-γRAW264.7 cellsulcerative colitis

Identifiers

PMID33380244
PMCPMC8806340
OpenAlexW3113606836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.